Castle Biosciences Inc logo

Castle Biosciences Inc

NAS:CSTL (USA)  
$ 21.23 +1.29 (+6.47%) 04:00 PM EST
At Loss
P/B:
1.48
Market Cap:
$ 582.76M
Enterprise V:
$ 331.85M
Volume:
416.82K
Avg Vol (2M):
254.93K
Volume:
416.82K
At Loss
Avg Vol (2M):
254.93K

Business Description

Castle Biosciences Inc logo
Castle Biosciences Inc
NAICS : 621511 SIC : 8071
ISIN : US14843C1053
Description
Castle Biosciences Inc is a commercial-stage dermatological cancer company. It is focused on providing physicians and their patients with personalized, clinically actionable genomic information to make more accurate treatment decisions. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Name Current Vs Industry Vs History
Cash-To-Debt 15.82
Equity-to-Asset 0.89
Debt-to-Equity 0.04
Debt-to-EBITDA -0.23
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.42
Distress
Grey
Safe
Beneish M-Score -2.49
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 31.57
9-Day RSI 35.26
14-Day RSI 39.42
6-1 Month Momentum % 20.45
12-1 Month Momentum % 3.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 7.7
Quick Ratio 7.54
Cash Ratio 6.33
Days Inventory 41.97
Days Sales Outstanding 54.12
Days Payable 59.89

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15.7
Shareholder Yield % -0.82

Financials (Next Earnings Date:2024-05-03 Est.)

CSTL's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:CSTL

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Castle Biosciences Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 192.006
EPS (TTM) ($) -2.84
Beta 1.12
Volatility % 70.75
14-Day RSI 39.42
14-Day ATR ($) 1.643679
20-Day SMA ($) 23.66254
12-1 Month Momentum % 3.59
52-Week Range ($) 9.2601 - 26.7
Shares Outstanding (Mil) 27.45

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Castle Biosciences Inc Filings

Filing Date Document Date Form
No Filing Data

Castle Biosciences Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Castle Biosciences Inc Frequently Asked Questions

What is Castle Biosciences Inc(CSTL)'s stock price today?
The current price of CSTL is $21.23. The 52 week high of CSTL is $26.70 and 52 week low is $9.26.
When is next earnings date of Castle Biosciences Inc(CSTL)?
The next earnings date of Castle Biosciences Inc(CSTL) is 2024-05-03 Est..
Does Castle Biosciences Inc(CSTL) pay dividends? If so, how much?
Castle Biosciences Inc(CSTL) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1